Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
N4 Pharma Plc |
8/12 | 0,525 GBX
-8,70% |
-8,70% |
Nanalysis Scientific Corp. |
9/12 | 0,145 CAD
-3,33% |
-3,33% |
Nano X Imaging Ltd |
9/12 | 3,580 USD
-4,02% |
-4,02% |
|
Nanobiotix |
8/12 | 21,030 USD
-0,57% |
-0,57% |
Nanobiotix |
9/12 | 18,340 EUR
+0,22% |
+0,22% |
NanoRepro AG |
8/12 | 1,575 EUR
+1,94% |
+1,94% |
|
NanoVibronix Inc |
8/12 | 4,440 USD
+6,99% |
+6,99% |
|
NanoViricides Inc |
9/12 | 1,370 USD
-4,20% |
-4,20% |
|
Natera Inc |
9/12 | 235,530 USD
-1,51% |
-1,51% |
|
Natural Alternatives International, Inc. |
9/12 | 3,120 USD
-2,50% |
-2,50% |
|
Navidea Biopharmaceuticals Inc |
8/12 | 0,000 USD
0,00% |
0,00% |
|
Nektar Therapeutics |
9/12 | 58,780 USD
+2,62% |
+2,62% |
|
Nemaura Medical Inc |
8/12 | 0,000 USD
-100,00% |
-100,00% |
|
Neogen Corp. |
8/12 | 6,040 USD
+1,00% |
+1,00% |
|
Neovacs |
8/12 | 0,013 EUR
-6,52% |
-6,52% |
|
Nephros Inc |
8/12 | 4,930 USD
-12,74% |
-12,74% |
|
NervGen Pharma Corp |
8/12 | 5,770 CAD
-0,52% |
-0,52% |
|
Neurocrine Biosciences, Inc. |
9/12 | 155,020 USD
+0,02% |
+0,02% |
|
Neuronetics Inc |
8/12 | 1,300 USD
-3,70% |
-3,70% |
|
Nextcure Inc |
8/12 | 11,300 USD
-8,39% |
-8,39% |
|
NIOX Group Plc
|
8/12 | 71,400 GBX
+1,71% |
+1,71% |
|
Nkarta Inc |
8/12 | 1,830 USD
+1,67% |
+1,67% |
|
NLS Pharmaceutics Ltd |
30/10 | 7,710 USD
+4,19% |
+4,19% |
|
Novabay Pharmaceuticals Inc |
8/12 | 1,550 USD
+28,10% |
+28,10% |
|
Novacyt |
9/12 | 0,448 EUR
+0,90% |
+0,90% |
|
Novartis AG |
9/12 | 131,010 USD
+0,65% |
+0,65% |
Novartis AG |
9/12 | 106,820 CHF
+0,17% |
+0,17% |
|
Novavax, Inc. |
9/12 | 6,660 USD
-1,77% |
-1,77% |
|
Novo Nordisk A/S |
9/12 | 46,360 USD
-0,88% |
-0,88% |
|
Novo Nordisk A/S |
9/12 | 40,180 EUR
-0,30% |
-0,30% |
|
NovoCure Ltd |
9/12 | 12,700 USD
+5,31% |
+5,31% |
|
NuCana plc |
8/12 | 4,140 USD
-0,72% |
-0,72% |
|
Nuformix plc |
8/12 | 0,255 GBX
0,00% |
0,00% |
|
Nurix Therapeutics Inc |
8/12 | 21,470 USD
+18,68% |
+18,68% |
|
Nutriband Inc |
8/12 | 4,940 USD
+2,49% |
+2,49% |
Nyxoah |
9/12 | 4,240 EUR
+0,47% |
+0,47% |